Zydus Wellness Q2 sales rise 74.6% as gross margin widens
Key highlights
- Zydus Wellness Q2 FY27 net sales rose 74.6% year on year to Rs 1,122.7 crore.
- Q2 FY27 gross margin increased 870 basis points to 61.1% from 52.4% a year earlier.
- Zydus Wellness reported Q2 FY27 PAT of Rs 5.1 crore, reversing a Rs 52.8 crore loss.
- H1 FY27 organised-channel saliency reached 38%, including 23% e-commerce and 15% modern trade.
powered by IRIS

Zydus Wellness Limited reported Q2 FY27 net sales of Rs 1,122.7 crore, up 74.6% year on year, and returned to a Rs 5.1 crore profit from a Rs 52.8 crore loss as gross margin expanded 870 basis points to 61.1%. The company said the higher-margin Comfort Click business further accelerated gross-margin expansion.
Know Zydus Wellness inside out
Results, valuation, peers and who's buying, in one view.
What did Zydus Wellness report for Q2 FY27?
Zydus Wellness reported net sales of Rs 1,122.7 crore in Q2 FY27, compared with Rs 642.9 crore in Q2 FY26, while revenue from operations increased 73.2% to Rs 1,126.6 crore. Gross contribution doubled to Rs 689.4 crore from Rs 344.2 crore, resulting in a gross margin of 61.1%, compared with 52.4% a year earlier.
Earnings before interest, tax, depreciation and amortisation, or EBITDA, rose to Rs 85.5 crore in Q2 FY27 from Rs 23 crore in Q2 FY26. EBITDA margin increased to 7.6% from 3.5%. Profit before tax, or PBT, was Rs 7.6 crore, reversing a Rs 50.6 crore loss, and profit after tax, or PAT, was Rs 5.1 crore against a Rs 52.8 crore loss.
How did Zydus Wellness sales grow across its businesses?
Zydus Wellness recorded 29.2% domestic revenue growth in Q2 FY27 and 12.4% international growth on a like-to-like basis that includes Comfort Click. In H1 FY27, domestic growth was 13.3%, while international growth was 18.6%. Domestic Q2 growth was therefore above its first-half rate, while international Q2 growth was below its H1 rate.
The domestic seasonal brands category, comprising Glucon-D and Nycil, grew 123.5% in Q2 FY27 but declined 8.7% in H1 FY27. Skin and hair care, which includes Everyuth Naturals and Cuticolor, grew 37.5% in Q2 and 35.8% in H1. The difference between seasonal-brand quarterly and half-year growth indicates that the Q2 recovery did not offset the earlier-period decline.
Food and nutrition, covering Complan, Sugar Free, Nutralite and RiteBite products, grew 25.1% in Q2 FY27 and 20.7% in H1 FY27. Zydus Wellness also reported organised-channel saliency of 38% in the domestic market during H1 FY27, up from 32% in H1 FY26 and 20% in H1 FY23. Modern trade accounted for 15% and e-commerce for 23% of the H1 FY27 organised-channel share.
Got a follow-up? Ask IRIS
Why did Zydus Wellness gross margin expand in Q2 FY27?
Zydus Wellness said gross-margin expansion continued in its core business and was further accelerated by the higher margin of Comfort Click. Gross margin rose by 870 basis points, or 8.7 percentage points, year on year to 61.1% in Q2 FY27 from 52.4% in Q2 FY26. H1 FY27 gross margin was 63.5%, up 980 basis points from 53.7% in H1 FY26.
The Q2 FY27 margin was below the preceding quarter's 65.5% in Q1 FY27 by 440 basis points. The presentation showed milk prices were 9.6% lower than Q2 FY26 but 3.8% higher than Q1 FY27, while edible-oil prices were 17.8% lower year on year but 4.5% higher sequentially. These comparisons show that annual input conditions improved while milk and edible-oil rates rose from the prior quarter.
Dextrose monohydrate was 8.3% lower than Q2 FY26 and 0.3% higher than Q1 FY27. Sucralose was 16.4% lower year on year and 1.6% lower sequentially, while stevia was down 13.8% from Q2 FY26 and 3.3% from Q1 FY27. These disclosed movements provide context for the 61.1% gross margin alongside the Comfort Click mix effect identified by management.
What constrained Zydus Wellness reported profit despite EBITDA growth?
Zydus Wellness said finance costs included interest expense on a euro-denominated loan used to fund the Comfort Click acquisition, while amortisation of acquired brands increased depreciation and amortisation expense. These factors help explain why Q2 FY27 EBITDA of Rs 85.5 crore translated into PBT of Rs 7.6 crore and PAT of Rs 5.1 crore despite the increase in operating margin.
Amortisation of acquired brands was Rs 49.4 crore in Q2 FY27, compared with Rs 18.7 crore in Q2 FY26, an increase of Rs 30.7 crore. Q2 FY26 also included Rs 34.2 crore of exceptional items, whereas Q2 FY27 had none. Zydus Wellness defines adjusted net profit as PAT before exceptional items and amortisation of acquired brands; adjusted net profit was Rs 54.5 crore in Q2 FY27, compared with Rs 0.1 crore a year earlier.
For H1 FY27, PAT increased 65.1% to Rs 124 crore from Rs 75.1 crore, while adjusted net profit rose 67.5% to Rs 222.4 crore from Rs 132.8 crore. H1 EBITDA grew 83.2% to Rs 327.2 crore, but PAT margin was 4.8%, compared with 5.0% in H1 FY26. The half-year comparison therefore shows higher absolute reported profit alongside a 0.2-percentage-point decline in PAT margin.
Conclusion
Zydus Wellness combined a 74.6% Q2 FY27 net-sales increase with an 870-basis-point gross-margin expansion and a shift from a Rs 52.8 crore loss to Rs 5.1 crore PAT. Domestic growth of 29.2%, food and nutrition growth of 25.1%, and the higher-margin Comfort Click contribution identified by management were central features of the quarter, while EBITDA margin increased from 3.5% to 7.6%.
The key unresolved factors to watch are input-rate movements and the costs linked to the Comfort Click acquisition. Milk prices were 3.8% higher sequentially and edible-oil prices were 4.5% higher in Q2 FY27, while acquired-brand amortisation was Rs 49.4 crore and finance costs included interest on the euro-denominated acquisition loan.


